✓Sep 14 session - Last update: Sep 14, 2026, 4:55 PM ET
🛡Material / Earnings✓High confidence
Source: daily_prices:fmp_change_percent
Changes History →Pre-market · Regular session opens 9:30 AM ET
Last update: Sep 14, 2026, 6:10 PM ETMarket closed·100 changes confirmed today
Track the stock moves that actually matter.
BestStocks detects meaningful changes across price, volume, earnings, filings, valuation, analyst revisions, and risk signals — and shows you the evidence behind each one.
1,000 equities monitored14 signal typesCross-checked against SEC EDGARMedian detection lag ~41s
Investment research built around change detection.
Showing:
BestStocks identifies what changed across companies and sectors, explains why it matters, and helps investors spot opportunities worth investigating.
✓Sep 14 session - Last update: Sep 14, 2026, 4:52 PM ET
🛡Material / Earnings✓High confidence
What changed: Kodiak Gas Services, Inc. (KGS) moved -7.12% from $60.96 to $56.62 on 2026-09-14 on significantly elevated volume (2.3x the 5-day average). We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move coincides with KGS reaching a new 30-day low.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor for any clarification on the Q2 2026 guidance increase announced recently, and track the next earnings report scheduled for 2026-11-03.
✓Sep 14 session - Last update: Sep 14, 2026, 4:57 PM ET
⚡Material / Earnings✓High confidence
What changed: Commvault Systems, Inc. (CVLT) moved +6.05% from $132.21 to $140.21 on September 14, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.7x the 5-day average, modestly elevated.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Commvault Systems earnings announcement on October 27, 2026.
✓Sep 14 session - Last update: Sep 14, 2026, 4:57 PM ET
⚡Material / Earnings✓High confidence
What changed: Twist Bioscience Corporation (TWST) moved +6.99% from $125.95 to $134.75 on September 14, 2026, driven by broader enthusiasm for AI-driven DNA demand and synthetic biology. The move follows strong fiscal Q3 results where the company reported revenue of $118.4 million, up 23% year-over-year, alongside upward guidance revisions. Institutional accumulation by major entities including the California State Teachers Retirement System and Engineers Gate Manager LP has also supported the share price.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
TWST earnings scheduled for November 13, 2026, with consensus EPS estimate of −$0.44.
✓Sep 14 session - Last update: Sep 14, 2026, 4:57 PM ET
⚡Material / Earnings✓High confidence
What changed: Hinge Health, Inc. (HNGE) moved +6.88% from $88.69 to $94.79 on 2026-09-14, extending a multi-week rally. The move reflects strong Q2 2026 results—revenue jumped 53% year-over-year to $212.8 million with raised full-year guidance—plus expansion into Migraine Care and gastrointestinal care through Cylinder Health, and recent analyst price target upgrades supporting confidence in the company's AI-powered platform.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Earnings scheduled for 2026-11-03 (date not yet confirmed) with a consensus EPS estimate of $0.67.
✓Sep 14 session - Last update: Sep 14, 2026, 4:56 PM ET
⚡Material / Earnings✓High confidence
What changed: Rigetti Computing, Inc. (RGTI) moved +5.08% from $14.53 to $15.27 on 2026-09-14, continuing momentum from its finalized $100 million federal award agreement with the U.S. government to accelerate superconducting quantum computing R&D.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Rigetti is scheduled to report earnings on 2026-11-09; consensus EPS estimate is −$0.05.
✓Sep 14 session - Last update: Sep 14, 2026, 4:54 PM ET
⚡Material / Earnings✓High confidence
What changed: Albertsons Companies, Inc. (ACI) moved +5.39% from $12.07 to $12.72 on 2026-09-14. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move coincided with ACI reaching a new 30-day high, with volume near its 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Earnings announcement on 2026-10-13 (date not yet confirmed); monitor whether the stock holds above $12.72 and how volume responds into the report.
✓Sep 14 session - Last update: Sep 14, 2026, 4:53 PM ET
🛡Material / Earnings✓High confidence
What changed: Archrock, Inc. (AROC) moved -5.52% from $32.27 to $30.49 on 2026-09-14. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move coincided with volume 1.8x the 5-day average and brought the stock to a new 30-day low.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Monitor AROC earnings on 2026-10-27 for actual EPS versus the $0.47 consensus estimate and any guidance updates.
✓Sep 14 session - Last update: Sep 14, 2026, 4:53 PM ET
⚡Material / Earnings✓High confidence
What changed: Hims & Hers Health, Inc. (HIMS) moved +5.22% from $27.38 to $28.81 on 2026-09-14. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was 1.5x the 5-day average, indicating modestly elevated trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Earnings report due 2026-11-02; watch for actual EPS result versus the $0.12 consensus estimate.
✓Sep 14 session - Last update: Sep 14, 2026, 4:52 PM ET
🛡Material / Earnings✓High confidence
What changed: EnPro Industries, Inc. (NPO) moved -5.74% from $301.21 to $283.94 on 2026-09-14. We checked news, earnings, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. The move appears to be technical, with NPO reaching a new 30-day low on near-average volume.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
NPO earnings scheduled for 2026-11-03; consensus EPS estimate is $2.40.
✓Sep 14 session - Last update: Sep 14, 2026, 4:51 PM ET
🛡Material / Earnings✓High confidence
What changed: Qorvo, Inc. (QRVO) moved -5.37% from $114.11 to $107.98 on September 14, 2026. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume remained near its 5-day average at 1.2x, indicating the decline occurred without unusual trading activity.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
QRVO earnings announcement on 2026-10-27 against consensus EPS of $2.03.
✓Sep 14 session - Last update: Sep 14, 2026, 4:51 PM ET
⚡Material / Earnings✓High confidence
What changed: Gartner, Inc. (IT) moved +5.90% from $186.09 to $197.07 on 2026-09-14. We checked news, earnings announcements, analyst updates, SEC filings, and corporate actions — no company-specific catalyst was found. Volume was modestly elevated at 1.5x the 5-day average.
Source: daily_prices:fmp_change_percent
Changes History →What's next
What to watch
Gartner earnings report on 2026-11-03, with consensus EPS estimate of $2.90.
Latest research
View all research →In-depth equity research from the BestStocks desk — earnings breakdowns, valuation deep dives, and sector analysis behind the changes we detect.
TechnologySeptember 9, 2026 · 8 min read
Meta (META) Jumps as Muse, Its First Paid Personal AI Agent, Puts a Price on AI
Meta rose about 6% to roughly $650 on September 9 after launching Muse, a personal AI agent — and, crucially, attaching a price to it: a free tier plus subscriptions at $20 and $100 a month. For a company that has spent enormous sums building AI infrastructure with little consumer revenue to show for it, Muse is a major new consumer-AI monetization line — its first paid personal-agent product — the proof of concept investors had been waiting for. Muse is an autonomous assistant that reads email, books travel, negotiates, and makes purchases through connected payment systems, rolling out in the US on iOS, Android and the web. The launch also rippled across the mega-caps: Alphabet fell ~2.6% as a capable buying-and-booking agent was read as a competitive threat to Google's search (Amazon also slipped ~2.1%, though it had its own news that day). The context is that Meta had lagged — down ~13% over the past year on AI-cost fears — despite an 82% gross margin, ~28% revenue growth and ~$41 billion of free cash flow, at just 19 times forward earnings. Muse does not resolve the spend-versus-return debate, but it reframes it, and the Street stays overwhelmingly bullish, with an average target implying ~16% upside.
METARead →
HealthcareSeptember 8, 2026 · 9 min read
Amgen (AMGN) Falls as a Rival's Lp(a) Trial Failure Clouds Its Pipeline
Amgen fell about 8% to roughly $404 on September 8 even as it posted its own good news that morning — its cancer drug IMDELLTRA, with AstraZeneca's Imfinzi, hit its primary survival goal in a Phase III lung-cancer study. The shares dropped anyway, on a rival's failure: Novartis disclosed late last week that pelacarsen — its drug for lowering lipoprotein(a), or Lp(a), a genetic cardiovascular risk factor — failed the primary goal of its large Phase III outcomes trial, not reducing heart attacks, strokes and cardiovascular deaths despite lowering Lp(a). Because Amgen is racing in the same class with its own experimental drug, olpasiran, the read-through was direct: the first dedicated Phase III cardiovascular-outcomes readout of an Lp(a) therapy came up empty, casting doubt on the science behind the category. A separate same-day BMO Capital downgrade — on valuation and pipeline grounds — formed part of the negative backdrop. What cushioned the fall is that Amgen is a cheap, cash-rich defensive franchise — about 18 times forward earnings, a 2.5% dividend, ~$10 billion of free cash flow — so the Lp(a) opportunity was upside, not the foundation. Even so, the stock had run up ~43% over the year, and the Street was already cautious, with a large share of analysts at Hold and an average target below the pre-drop price.
AMGNRead →
TechnologySeptember 8, 2026 · 8 min read
Intel (INTC) Jumps on a High-NA EUV Milestone, Ahead of TSMC in Deployment
Intel rose about 8% to roughly $103 on September 8 after it and lithography partner ASML announced they have processed more than one million wafers using High-NA EUV — the newest, most advanced chipmaking lithography, by industry accounts more than any rival has run. Intel is deploying the technology on select layers of certain 18A products (chips such as Panther Lake), and reports throughput and yields meeting expectations, giving it a multi-year lead in High-NA production experience — TSMC is generally expected to bring High-NA into high-volume production around 2030, and Samsung targets it for DRAM around 2028. The milestone was the headline, though the stock also had a same-day analyst upgrade and reports of possible processor price increases. For a company whose whole case rests on rebuilding a credible foundry business, it was tangible proof the turnaround is producing real capability. The move caps a staggering ~322% one-year run — yet the fundamentals lag: Intel is still GAAP-unprofitable, and the Street stays cautious, with a Hold consensus (roughly two-thirds of covering analysts on the sidelines) and an average target only about 12% above the price. One firm (Northland) upgraded to Buy on the news; most are waiting for the manufacturing lead to become profit.
INTCRead →
TechnologySeptember 3, 2026 · 8 min read
Snowflake (SNOW) Jumps 16% on a Q2 Beat-and-Raise as a Software Pop Fades
Snowflake jumped as much as 26% intraday to a 52-week high of $384.56, then pared the gain to close up about 16.5% at $356.47, after reporting fiscal second-quarter results the evening before that beat and — the part that moves stocks — raised full-year guidance. Product revenue re-accelerated to about 37% growth ($1.49 billion), adjusted earnings of about $0.62 topped the ~$0.45 expected, and management lifted its full-year product-revenue target to roughly $6.07 billion while widening its margin outlook. The beat-and-raise sparked a sympathy surge across software — Datadog and MongoDB edged higher — on the idea that AI is a tailwind rather than a threat, but that broader enthusiasm largely faded by the close, leaving both peers up only about 2.5% while Snowflake held its gain. The catch is the price: after a ~55% year, Snowflake trades near 15 times forward sales and is still GAAP-unprofitable on heavy stock comp, though it closed somewhat below the average analyst target even after a wave of same-day target increases.
SNOWRead →
TechnologySeptember 1, 2026 · 8 min read
Apple (AAPL) Rises as Ternus Takes Over and the Sept. 9 iPhone Event Nears
Apple rose about 2.5% to roughly $325 on September 1, and the striking part was the company it kept: on a risk-off day driven by rising Treasury yields, Apple was one of the very few large-caps to rise — Meta also gained — while Microsoft, Nvidia and Alphabet slipped alongside the Nasdaq-100. The day carried two milestones. A long-planned leadership handover took effect: John Ternus, the hardware engineer behind the iPhone and Vision Pro, became CEO, with Tim Cook — chief executive since 2011 — moving to executive chairman; the succession was announced back in April, so this was the orderly handover, not fresh news. And Apple's September 9 event, expected to unveil the iPhone 18 Pro and a first foldable, is days away. The catch is valuation: at about 36 times earnings, after a ~40% run, the stock sits right at its average analyst target and about 6% below its late-July record — and the Street is split, with a Bernstein $370 bull case against a rare Jefferies bearish call (an Underperform near $264).
AAPLRead →
IndustrialsSeptember 1, 2026 · 8 min read
Deere (DE) Hits a Record High After a Baird Upgrade on a 2027 Ag Recovery
Deere rose about 2.6% to a record high near $676 on September 1, standing out on a day technology and semiconductors sold off. The catalyst was dated and company-specific: a day earlier, Baird's Mircea Dobre upgraded Deere to Outperform and raised his price target to $800 from $640, arguing North American crop economics improve in 2027 — corn back above breakeven, better soybean margins, tighter stocks-to-use. Baird upgraded AGCO the same day, and both farm-equipment makers rose while construction bellwether Caterpillar fell, isolating an agriculture-specific move rather than a broad machinery rally. The puzzle is the valuation: Deere trades at about 36 times trailing earnings, but that reflects an expected fiscal-2026 revenue trough (down ~10% on consensus estimates), with fiscal-2027 modeled up ~8% — the recovery the upgrade is betting on. The catch: after a ~40% run to a record, the Street is split, with 11 of 24 analysts at Hold and an average target just below the price.
DERead →